The U.S. Food and Drug Administration has given the go-ahead for new COVID-19 vaccines this fall, introducing the most stringent guidelines on vaccine eligibility since their initial availability.
Secretary of Health and Human ServicesRobert F. Kennedy Jr.declared approval on August 27thsocial media platform X,claiming that emergency use authorizations for COVID-19 vaccines have ended, and that the Moderna, Pfizer, and Novavax vaccines are now approved for “individuals at high risk.”
Under the updated approvals, Only individuals aged 65 and older, as well as those with pre-existing medical conditions, will be advised to receive the COVID-19 vaccine, as outlined in federal guidelines.
Begin your day with more knowledge. Receive all the news you need in your email every morning.
“The vaccines are accessible to all patients who opt for them following a discussion with their physicians,” Kennedy stated in the post.
HHS repeated the statement in a Q&A document provided to USA TODAY, stating, “The current ruling does not impact access to these vaccines for healthy people. These vaccines continue to be available to those who opt for them after discussing with their doctor.”
The shift is from a situation where vaccines were marketed through both the emergency use authorization and the standard approval process, to a situation where COVID-19 vaccines are now only marketed through the standard approval pathway,” the document stated. “This does not mean that COVID-19 vaccines are being taken off the market.
Pfizer said in a news releasethat its updated formulation has been authorized for use in all adults aged 65 and older, as well as individuals over the age of 5 who have at least one underlying medical condition that increases their risk of severe illness due to COVID-19.
Moderna likewise saidThe updated Spikevax formulation has been approved for individuals over 65 and those aged 6 months and older with at least one health condition that increases their risk. The new vaccine, mNEXSPIKE, has been authorized for people with a pre-existing condition who are 12 years old or older and for all individuals over 65.
Reports of a vaccine ban are “without basis,” the White House states.
Kennedy said May 27 regarding the COVID-19 vaccinewould no longer appear on the CDC’s advised vaccination schedule for healthy children and expectant mothers, a step thatbroke with expert guidanceand skipped the standard scientific evaluation procedure.
Experts have warnedthat the updated guidance might create additional challenges for those seeking the COVID-19 vaccine, as insurance companies typically adhere to federal recommendations.
Rumors suggested that Kennedy intended to prohibit the vaccine entirely, which spread in late August following a reportfirst released by The Daily Beaston August 25, citing cardiologist and Kennedy associate Dr. Aseem Malhotra, the report stated that the HHS would attempt to remove the COVID-19 vaccine from the U.S. market “within a few months,” a claim theWhite House dismissed as “baseless speculation.”
Medical organizations, doctors
The American Academy of Pediatrics, which has recentlyexchanged words with Kennedyregarding vaccine suggestions, they described the new guidelines as “extremely concerning” in astatement released Aug. 27.
Any parent wishing to have their child vaccinated should be able to access this vaccine; today’s extraordinary move by HHS not only blocks this possibility for numerous families, but also creates more confusion and anxiety for parents striving to make the best decisions for their children,” said Dr. Susan J. Kressly, president of the academy. “Parents and pediatricians, working together, make the most effective choices to ensure children’s long-term well-being. We call on the Administration to let these decisions stay in the hands of medical professionals and families.
Jennifer Nuzzo, an epidemiologist and head of the Pandemic Center at Brown University’s School of Public Health, also stated to USA TODAY that specialists are concerned about the way federal organizations are conveying vaccine guidelines to the general population.
Nuzzo stated, ‘My primary worry is that the confusion and anxiety these changes are creating will, in reality, hinder people from receiving vaccines.’
Vaccine battle continues
Although the new, more strict rules have not gone as far as a complete prohibition, Kennedy’s doubt regarding the vaccinecontinues to be a subject of debatebetween the HHS and other health organizations.
State health departments and national professional groups, such as the American Academy of Pediatrics, the American Medical Association, and the American College of Obstetricians and Gynecologists,openly criticized Kennedy in Maywhen he stated his plans to cease advising on the COVID-19 vaccine for pregnant individuals and healthy children.
He later faced increased criticism when he terminatedall 17 original membersfrom the Advisory Committee on Immunization Practices, the group of health professionals that offers recommendations regarding vaccine usage to the CDC,replacing them with memberswho critics have deemed unfit. Some individuals, such as Kennedy, have a background in opposing vaccines and participating in anti-vaccine organizations.
The American Academy of Pediatrics took it to the point ofrelease its own schedule August 19, stating that the federal process is no longer trustworthy. It suggests that all children between 6 months and 23 months should get the most recent COVID-19 vaccine to lower the risk of severe illness. Children and teenagers aged 2 to 18, who do not have additional high-risk conditions such as a weakened immune system, should be offered the vaccine if they were not previously vaccinated, as per the guidelines.
In a reply shared on social media,Kennedy responded to the pediatrics academy’s negative comments, suggesting that the organization’s stance in favor of vaccines was shaped by financial support from corporate pharmaceutical companies.
With Kennedy, the updated CDC guidelines avoid offering specific recommendations and instead advise parents to discuss individual situations with their child’s pediatrician.
This tale has been revised with additional details.
Contributing: Ken Alltucker
This piece first was published on USA TODAY:RFK Jr.’s FDA approves new COVID vaccines but with limitations
